Physician profile
Mark E Reader
NPI 1649363334
$1,054.40
in general payments reported to CMS, 2019-2025
9 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $363 · 2020: $25.44 · 2021: $49.26 · 2022: $95.95 · 2023: $291 · 2024: $129 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $521.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $520.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $307.94 | 2019-2023 | Clarifix Cryotherapy Device |
| Oticon Medical, LLC | $178.47 | 2024-2025 | Ponto Bone Anchored Hearing System |
| Medtronic, INC. | $166.90 | 2023 | Propel, Sinuva |
| Smith+Nephew, INC. | $99.64 | 2021-2022 | |
| Acclarent, INC | $91.83 | 2019-2023 | Trudi Nav Cable |
| Intersect Ent, INC. | $73.05 | 2019 | |
| Cochlear Americas | $50.81 | 2019-2025 | Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha |
| Merck Sharp & Dohme LLC | $48.75 | 2022-2025 | Bridion |
| Aerin Medical INC. | $37.01 | 2021-2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Reader listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.